You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 6, June 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prediction of Language and Neurologic Recovery After Cerebral Infarction With SPECT Imaging Using N-Isopropyl-p-(I 123) Iodoamphetamine

David L. Bushnell, MD; Sudha Gupta, MD; Anthony G. Mlcoch, PhD; W. Earl Barnes, PhD

Arch Neurol. 1989;46(6):665-669.


Abstract

• Fourteen patients (10 with left-sided and 4 with right-sided cerebral infarction) were prospectively studied with single-photon emission computed tomography (SPECT) using N-isopropyl-p-(1 123) iodoamphetamine (IMP, SPECTamine) to determine its usefulness in predicting neurologic/language recovery after cerebral infarction. All neuro-SPECT imaging was performed within 30 days after infarction. Detailed assessment of neurologic and/or language recovery (after 3 months) was carried out prospectively in each patient. Patients with smaller volume IMP defects in the region of infarction demonstrated significantly better neurologic and language recovery than patients with large IMP defects. Analysis of the IMP "redistribution" phenomenon failed to demonstrate definitively a relationship with clinical recovery. It was concluded that the volume of the IMP defect can aid in predicting recovery potential after cerebral infarction.



Author Affiliations

From the Nuclear Medicine (Drs Bushnell and Barnes), Neurology (Dr Gupta), and Audiology and Speech Pathology (Dr Mlcoch) Services, Hines (Ill) Veterans Administration Hospital, the Departments of Neurology (Dr Gupta) and Otorhinolaryngology (Dr Mlcoch), Loyola University Medical School, Maywood, Ill, and the Department of Internal Medicine, Chicago Medical School, North Chicago, Ill (Dr Bushnell).


Footnotes

Accepted for publication December 14, 1988.

Reprint requests to Nuclear Medicine Service, Hines Veterans Administration Hospital, Hines, IL 60141 (Dr Bushnell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Single-Photon Emission Computed Tomography Using Hexamethylpropyleneamine Oxime in the Prognosis of Acute Cerebral Infarction
Bowler et al.
Stroke 1996;27:82-86.
ABSTRACT | FULL TEXT  

Comparative Correlations of HMPAO SPECT Indices, Neurological Score, and Stroke Subtypes With Clinical Outcome in Acute Carotid Infarcts
Laloux et al.
Stroke 1995;26:816-821.
ABSTRACT | FULL TEXT  

Regional Cerebral Blood Flow After Human Cardiac Arrest: A Hexamethylpropyleneamine Oxime Single Photon Emission Computed Tomographic Study
Roine et al.
Arch Neurol 1991;48:625-629.
ABSTRACT  

Pharmacologic Modulation of Recovery After Brain Injury: A Reconsideration of Diaschisis
Feeney
Neurorehabil Neural Repair 1991;5:113-128.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.